Biopharmaceuticals
Drug Delivery
News Release - October 2, 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
Source: PowderMed
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.